Pelthos Therapeutics, Inc.

Contributing Author

Recent Articles by Pelthos Therapeutics, Inc.

May-14	Pelthos Therapeutics Announces First Quarter 2026 Financial Results PTHS +6.46% GlobeNewswire
May-01	Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 PTHS GlobeNewswire
Apr-14	Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium PTHS GlobeNewswire
Apr-10	Pelthos Therapeutics Announces CFO Transition PTHS GlobeNewswire
Mar-31	Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain PTHS GlobeNewswire
Mar-19	Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results PTHS GlobeNewswire
Mar-12	Pelthos Therapeutics to Present at 38th Annual ROTH Conference PTHS GlobeNewswire
Mar-09	Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 PTHS GlobeNewswire
Feb-23	Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference PTHS +5.04% GlobeNewswire
Jan-13	Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance PTHS GlobeNewswire
Jan-05	Pelthos Therapeutics Acquires Xeglyze (abametapir) Topical Treatment for Head Lice PTHS -9.03% GlobeNewswire
Dec-23	Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn PTHS GlobeNewswire
Dec-04	Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI (berdazimer) Topical Gel, 10.3% PTHS GlobeNewswire
Dec-02	Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference PTHS GlobeNewswire
Nov-13	Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results PTHS -7.27% GlobeNewswire
Nov-07	Pelthos Therapeutics Acquires Xepi (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing PTHS -8.07% GlobeNewswire
Nov-05	Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 PTHS +6.47% GlobeNewswire
Oct-09	Pelthos Therapeutics Launches Moms Against Molluscum Movement to Unite Families Affected by Molluscum Contagiosum PTHS -7.89% GlobeNewswire
Sep-08	Pelthos Therapeutics to Participate in Upcoming September Investor Conferences PTHS +13.96% GlobeNewswire
Sep-02	Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference PTHS -5.03% GlobeNewswire
Aug-18	Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update PTHS GlobeNewswire

Pelthos Therapeutics, Inc.

Recent Articles by Pelthos Therapeutics, Inc.

Upgrade your Finviz experience